ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
A10BB12 | G | Glimepiride - 2mg | 5098 | 24398 | SENSEDIA | 2mg | 30 | Tablet | Oral | Droguerie de l'Union | Algorithm S.A.L. | Lebanon | 255,675 L.L | 23.08 | A1 | 2/1/2023 |
ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
A10BB12 | B | Glimepiride - 2mg | 10880 | 27922/1 | AMARYL | 2mg | 30 | Tablet | Oral | Mersaco | Sanofi SpA | Italy | 164,594 L.L | 23.08 | A1 | Sanofi Aventis Deutschland GmbH | Germany | 2/1/2023 |
A10BB12 | B | Glimepiride - 2mg | 5400 | 222465/08 | AMARYL 2MG | 2mg | 30 | Tablet | Oral | Mersaco | Benta SAL under license from Sanofi Aventis Deutschland GmbH Germany | Lebanon | 305,405 L.L | 23.08 | A1 | 2/1/2023 | ||
A10BB12 | G | Glimepiride - 2mg | 4729 | 148221/03 | DIAMERIL | 2mg | 30 | Tablet | Oral | Pharmaline S.A.L. | Pharmaline SAL | Lebanon | 162,162 L.L | 23.08 | A1 | 2/1/2023 | ||
A10BB12 | G | Glimepiride - 2mg | 6838 | 168002/10 | GLIM | 2mg | 30 | Tablet | Oral | Khalil Fattal & Fils S.A.L. | Spimaco | Saudi Arabia | 282,838 L.L | 23.08 | A1 | Spimaco | Saudi Arabia | 2/1/2023 |
A10BB12 | G | Glimepiride - 2mg | 6705 | 219306/09 | GLYPRIDE | 2mg | 30 | Tablet | Oral | Pharmanet Drugstore S.A.R.L. | Julphar | United Arab Emirates | 283,784 L.L | 23.08 | A1 | Julphar | United Arab Emirates | 2/1/2023 |
A10BB12 | G | Glimepiride - 2mg | 5927 | 222483/08 | JOSWE GLEMAX 2 | 2mg | 30 | Caplet | Oral | The Lebanese Pharmacists SAL | Joswe Medical (Jordan Sweden Medical and Sterilization Co) | Jordan | 229,865 L.L | 23.08 | A1 | 2/1/2023 | ||
A10BB12 | G | Glimepiride - 2mg | 5122 | 24524/07 | ORBIDE | 2mg | 30 | Tablet | Oral | Codipha | Pharmadex licensed by Orbucell pharma Canada | Lebanon | 418,018 L.L | 23.08 | A1 | 2/1/2023 |